Brief: Adaptive Biotechnologies Reports First Quarter 2023 Financial Results
03/05/2023 23:27
May 4 (Reuters) - Adaptive Biotechnologies Q1 EPS USD -0.4 * Outlook FY revenue USD 205-215 million * Q1 revenue USD 37.6 million * Q1 operating expenses USD 94.8 million * Q1 adjusted EBITDA USD -37.1 million * Q1 net income USD -57.7 million
Recent news on Adaptive Biotechnologies
See all newsAdvisory: Alert incorrectly tagged to Adaptive Biotechnologies withdrawn
U.S. RESEARCH ROUNDUP-Cloudflare, Replimune, Walmart
U.S. RESEARCH ROUNDUP-Equinix, Meta, S&P Global
Adaptive Biotechnologies Corp reports results for the quarter ended June 30 - Earnings Summary
Adaptive Biotechnologies Q2 revenue rises 22%, beats estimates